DOCSLIB.ORG

Loma Linda Publishing Company Acquires

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Loma Linda Publishing Company Acquires NEONATOLOGY TODAY News and Information for BC/BE Neonatologists and Perinatologists Volume 14 / Issue 2 February 2018 Loma Linda Publishing Company In This Issue Acquires Neonatology Today Loma Linda Publishing Company Acquires By Mitchell Goldstein, MD Neonatology Today By Mitchell Goldstein, MD “After significant vetting, it ~Page 1 I would like to start off by thanking Tony Carlson, Dr. John Moore and Richard was decided that the Neonatology Today Koulbanis for starting Neonatology Today Division of Neonatology in 2006-2018: A Brief History and creating what I believe is the most the Department of By Tony Carlson, Founder provocative format for publication in Neonatology. Over the many years that I ~Page 3 Pediatrics at Loma Linda received the publication, I have seen it Effect of Type of Feeding on develop into a very contemporary source of University School of Infants with Neonatal new information, all while literally embracing the field of Neonatology. Medicine would fund the Abstinence Syndrome creation of a not-for-profit By Ahmad Aboaziza, MD; Darshan At the Pediatric Academic Society Meeting Shah, MD; Jennifer Gibson MD; this past spring, Tony Carlson and I had publishing company that Des Bharti, MD lunch. We discussed the future of would acquire Neonatology ~Page 4 Neonatology Today. As President of the National Perinatal Association, I and the Today.” Effective FiO2 While Using organization as a whole had contributed Vapotherm: Weaning Flow Is significantly to the volume of published as Important as Weaning manuscripts. Tony wondered whether I Oxygen might be interested in running the accommodate the demand. My commitment will be to provide By Shabih Manzar, MD publication. We both left the meeting feedback on any submission in fewer ~Page 10 motivated to see if we could make this work. After exploring several options for a new than 14 business days. Can People Heal as They home for Neonatology Today, and much 2. We will actively solicit and publish case reports that provide insights into Grieve? thought and careful consideration, I management of complex conditions By Andrea Werner Insoft, LICSW, determined the best course for Neonatology Today would be to bring it to a respected confronting practicing neonatologists. ACSWD Although many journals have ~Page 11 academic institution with experience in fact-based writing, editing and publishing. discouraged case report submission, it is our feeling that these provide a way Establishing a Robust This led me to discussions with the academic division at Loma Linda University. of disseminating meaningful academic Transcatheter PDA Closure information that may not otherwise see Program for Extremely Low After significant vetting, it was decided that the light of day. Birth Weight Infants the Division of Neonatology in the 3. We will be making Neonatology Today By Shyam Sathanandam, MD; Department of Pediatrics at Loma Linda a multidisciplinary publication, open to Leah Apalodimas, MSN, APN, University School of Medicine would fund all professionals who engage in CCRN, CPNP; Mark Weems, MD; the creation of a not-for-profit publishing academic pursuits in the fields of B. Rush Waller, MD; Ranjit Philip, company that would acquire Neonatology Neonatology, Perinatology, and MD Today. As such, it gives me great pleasure Pediatrics. 4. We hope to increase our readership ~Page 12 to announce the formation of Loma Linda Publishing Company (A 501-C3 Delaware by striving to be first to report on Medical News, Products & Corporation). From March 2018, we will innovative new concepts in all of the Information assume publication control of Neonatology associated specialties. 5. We will expand our readership by ~Page 18 Today from Tony, John and Richard. adding an international component to Upcoming Medical Meetings What does this mean for you, our readers? our board. ~Page 22 6. We will continue to commit to not We plan on continuing the current look and charge authors for publication of their feel of the publication and will continue to manuscripts. NEONATOLOGY TODAY publish monthly. But there will be some 7. Highlighting the work of The patient © 2006-2018 by Neonatology Today changes “under the hood.” and provider advocacy community ISSN: 1932-7137 (online) including organizations like the Published monthly. All rights reserved 1. All manuscripts submitted will be National Coalition for Infant Health peer-reviewed. I will be contacting our (NCfIH),(infanthealth.org). www.NeonatologyToday.net editorial board and plan to add 8. We will start having monthly open Twitter: www.Twitter.com/NeoToday additional reviewers as needed to conference calls for our readers to Because jaundice can translate to big risk for newborns Visit Booth #105 or SeeJaundiceDifferently.com to sign up for further updates. Each year, more than 800,000 newborns in the In 2004, the American Academy of Pediatrics published United States are diagnosed with neonatal jaundice.1 guidelines for the management of hyperbilirubinemia.3 Some babies may not fully respond to current therapies and Since then, there have been only modest treatment may require additional interventions, leaving them exposed advancements in jaundice. The current standard of care to elevated levels of bilirubin for a long duration of time.2 requires periods of isolation that can compromise the potential of the mother-infant bond.5 It is unknown what levels of bilirubin start to trigger potentially toxic effects in an individual newborn. Left Mallinckrodt is committed to researching and advancing uncontrolled, elevated bilirubin can lead to neurologic the understanding of neonatal jaundice. dysfunction, encephalopathy, or irreversible brain damage.3,4 REFERENCES: 1. Healthcare Cost and Utilization Project (HCUP) Kids’ Inpatient Database (KID). https://www.hcup-us.ahrq.gov/reports/factsandfi gures/HAR_2006.pdf. Accessed January 3, 2018. 2. Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. Am Fam Physician. 2014;89(11):873-878. 3. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316. 4. Dennery PA, Seidman DS, Stevenson DK. Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks Neonatal hyperbilirubinemia. N Engl J Med. 2001;344(8):581-590. 5. Kappas A. A method for of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their interdicting the development of severe jaundice in newborns by inhibiting the production respective owners. of bilirubin. Pediatrics. 2004;113(1, pt 1):119-123. ©2018 Mallinckrodt. US PRC/NATS/0118/0008 01/18 SeeJaundiceDif erently.com “... it gives me great Neonatology Today 2006-2018: pleasure to announce the A Brief History formation of Loma Linda by Tony Carlson, Founder Publishing Company (A 501-C3 Delaware In the early 1990’s, my neighbor was Dr. John Moore, a well-known Pediatric Cardiologist and currently Director, Division of Cardiology at Rady Children’s Corporation). From March Hospital. Our kids were close in age and played the same sports. John and I spent many years watching our kids grow up and play sports together. One day 2018, we will assume I asked John what he did. He said he was a Pediatric Cardiologist and I asked publication control of what is that. He said it is like being a “plumber” for children with heart problems. I told him that I created and published custom publications for Neonatology Today from technology companies like Microsoft, HP, and others focused on solving Tony, John and Richard.” problems for their customers. John felt there was no publication focused on Pediatric Cardiology because the Cardiology market was 90% adult and 10% children. After 10 years of talking about it, we finally launched Congenital Cardiology Today (CCT) in September 2003, and it was very well-received! We comment on and make suggestions are now in our 16th year as a worldwide monthly publication. on how to make NT a better publication. When I met Dr. Alan Spitzer in 2004, he was a Neonatologist and a Pediatric 9. We will have a dedicated message Cardiologist at PEDIATRIX. We met at various cardiology and neonatology line for questions, concerns, and meetings including Tiny Baby (now NEO, The Conference for Neonatology). comments. We talked about the possibility of a medical publication focused editorially on 10. We will continue to provide the Neonatology, Perinatology and the NICUs with a similar format as CCT. Alan journal for free to our readers. agreed that the benefits of a similar publication for Neonatologists, Perinatologists and their NICU teams would be a needed resource. In May I look forward to serving you. 2006, we launched the first monthly issue of Neonatology Today. We now have 4,000 readers (Neonatologists, Perinatologists, and their NICU teams of Sincerely, Fellows, and NNPs) at 1,045 NICUs throughout the USA and Canada. Mitchell Goldstein, MD I met Dr. Mitchell Goldstein, Director of Neonatal ECMO at Loma Linda Editor-In-Chief University Children’s Hospital, and have known each other for many years. With Neonatology Today Mitchell’s NICU experience and being a prolific writer, it was a good NT match from the start. He was added to the Neonatology Today Editorial “On behalf of my two Board, and since then he has Corresponding Author authored many quality articles that business partners, Dr. we published. As I “matured” and wanted more time to spend with my John Moore, and Richard grandkids, I asked Mitchell if he Koulbanis, I want to thank would be interested in running the publication. I wanted to make sure our readers and the Neonatology Today would be in the companies that have best hands. And the rest is history. supported us for making On behalf of myself and my two business partners, Dr. John Moore, my dream become a and Richard Koulbanis, I want to reality for the past 12 Mitchel Goldstein, MD thank our readers and the Editor-in-Chief companies that have supported us years.” Neonatology Today for making our dream become a Loma Linda Publishing Company reality for the past 12 years.
Load more

Recommended publications
  • Internal Medicine – Focus on Pediatrics/Neonatology Learning Experience 1 & 2
    CONTROLLED UNLESS PRINTED PGY1 – Internal Medicine – Focus on Pediatrics/Neonatology Learning Experience 1 & 2 Preceptors* Emily Siegrist, PharmD ([email protected]) Deanna Dickson, PharmD ([email protected]) Elaine Rietmann, PharmD ([email protected]) Hours: 0700 to 1730 *Primary preceptors and preceptors will be assigned dependent on pharmacist schedule during rotation General Description This rotation is concentrated in four weeks of exposure to the pediatric and neonatal populations at Asante Rogue Regional Medical Center. The clinical pharmacist on the team is responsible for ensuring safe and effective medication use for all patients admitted to the pediatric and neonatal intensive care unit. Routine responsibilities include: review and confirmation of appropriateness of medication for the patient population based upon age, weight, indication and pharmacokinetic considerations; completion of consults and medication therapy protocols in areas including dosing and monitoring of TPN, kinetics, evaluation of anti-infectives, addressing formal consults for non-formulary drug requests and providing patient and family education. The pharmacist also provides drug information and education to healthcare professionals as requested. Expectations of the Resident Residents will attend NICU and Pediatric rounds every day. During this rotation the resident will focus on caring for patients in the pediatric and neonatal intensive care units. Residents will actively seek to identify the potential for significant medication-related
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • OTITIS MEDIA (OM): a COMMON COMPLICATION OFNASOTRACH- AMNIOTIC Nuid - DIAGNOSIS USING B2 MICROGLOBULIN
    NEONATOLOGY TUBULAR DYSFUNCTION IN INFANTS WITH MECONIUM STAINED OTITIS MEDIA (OM): A COMMON COMPLICATION OFNASOTRACH- AMNIOTIC nUID - DIAGNOSIS USING B2 MICROGLOBULIN. EAL INTUBATION (NTI) IN THE NEONATE. Janet Purn, Ilana t 1469 Ronald J.Portman, Jennifer W.Cole, Jeffrey M.Perlman, 1472 Zarafu, (Spon. Franklin C. Behrle) Univ. of Medicine Yin Lim, Alan M.Robson, Washington Univ. Sch. of Med., St.Louis and Dentistry: New Jersey Medical School, Newark Beth Israel Med- Children's Hospital, Department of Pediatrics, St.Louis, MO ical Center (NBIMC) Dept. of Peds., Newark, N. J. 07112 Urinary concentrations of B2 microglobulin (B2M) and creatin- Auditory Brainstem Responses (ABR) are recorded in the Newborn ine were measured in normal term infants and in those born with Special Care Center at NBIMC prior to discharge.From 9/82 to 8/83 meconium stained amniotic fluid (MEC). None of the infants or 252 infants (INFS) had ABR evaluations. One hundred one INFS were their mothers had conditions known to modify B2M excretion. Apgar ventilated through endotracheal tube. They were assessed by ABR scores for the normal and MEC infants averaged 8.8 and 7.7 re- and otoscopy~ta mean postnatal age of 39 days (D). The mean spectively at 1 min and 9.0 and 8.2 at 5 min. Urinary B2M to cre- birthweight (BW) of intubated INFS was 1895gms (580-4170), and mean atinine levels (mglgm) increased significantly (~<.01)in the duration of intubation was 5.8 D. NTI was used in 98 INFS,oral in- normal infants from day 1 (1.5+1.3:n=29) to day 3 (3.5+2.B:n=21) tubation in 3 and 18 had NTI and oral tubes.
    [Show full text]
  • Eric D. Schultz, DO, MPH
    Eric D. Schultz, DO, MPH EDUCATION 07/2005-06/2008 Duke University Medical Center Durham, NC Neonatal-Perinatal Intensive Care Fellowship 07/2002-06/2005 University of California, Irvine Orange, CA Pediatric Residency 08/1998-06/2002 Western University of Health Sciences Pomona, CA D.O. 08/1993-05/1996 California State University, San Diego San Diego, CA M.P.H.: Epidemiology 09/1988-06/1993 University of California, San Diego La Jolla, CA B.A.: Chemistry/Biochemistry PROFESSIONAL EXPERIENCE 03/2011 – Present Texas A & M College of Medicine Round Rock, TX Clinical Assistant Professor: Dept. of Pediatrics 09/2010 – Present Greater Austin Allergy, Asthma & Immunology Austin, TX Allergy, Asthma and Immunology Physician 09/2010 – 09/2016 Sneeze Allergy, Cough and Sinus Centers Austin, TX Chief Medical Officer AN EXPERT APPROACH TO ALLERGY RELIEFSM • AUSTINALLERGIST.COM 06/2010 – 09/2010 Pediatric Subspecialty Faculty Orange, CA Associate Director of Neonatal-Perinatal Education 04/2010 – 09/2010 University of California, Irvine Orange, CA Clinical Instructor: Division of Neonatology 06/2009 – 09/2010 Children’s Hospital of Orange County Orange, CA Neonatologist 07/2008 – 06/2009 Rady Children’s Hospital of San Diego San Diego, CA Neonatologist 07/2008 – 06/2009 Sharp Mary Birch Hospital San Diego, CA Neonatologist 10/2006 – 06/2008 Columbus Regional Hospital Whiteville, NC Pediatric Hospitalist GRANTS Duke University Medical Center Children’s Miracle Network Grant T32 NIH National Research Service Award AN EXPERT APPROACH TO ALLERGY RELIEFSM • AUSTINALLERGIST.COM CLINICAL TRIALS 2006-2008 Principal Investigator: Duke University. Children’s Miracle Network Grant. Blocking mast cell homing prevents airways hyperreactivity in hyperoxia exposed newborn rats.
    [Show full text]
  • Effects of Severe Hypoxia on Dilator Prostaglandin Synthesis
    NEONATOLOGY 325A MYOINOSITOL SUPPLEMENTATION IN RESPIRATORY DISTRESS THROMBOXANE B LEVEL S IN NEONATES WITH PERSISTENT SYNDROME (RDS). Mikko Hallman, Anna-Liisa FETAL CIRCULAfiON. Cathy Harrunerman, Elene Strates, Pat Bromberger. Childrens' Hosp ital, Univ. Helsinki, Stuart Berger and W1lliam Za1a. (Spon . by K.S. Lee), Fi nland; Univ. California, San Diego, CA . University of Chicago Medical Center, Department of Pedi atrics, Myoinositol (INO) may potentiate hormone-induced lung matura­ Chicago, IL. tion & increase surfactant in lung damage (Ped Re • 17 , 378A,-83; Plasma levels of Thromboxane B2 (TxB 2) were determined by Life Sci 31, 175,-82). Serum INO is high in RDS at birth. INO de­ radioimmunoassay in seven infants with persistent fetal circu la­ creases after bi rth , in part because the diet may contain only tion (PFC) of various etiologies. The levels were found to be little INO. In the present randomized double-blind trial involv­ quite elevated as compared with those of seven neonates with ing 22 RDS cases (BW <2000g), we studied the effect of INO on other cardiorespi ratory problems, but without PFC: serum INO and on lung phospholipids . Either INO or glucose (GLU) MEAN (dose: 1 ml isotonic sugar/kg q 6 h) was given orally for 7 days, PFC 2426 12 2540 585 591 628 331 1016.!:_1025 beginning da y two. The amount of INO was similar to. INO in 200 ml/kg of preterm breast milk. There was no d1fferences 1n Controls 282 34 237 188 99 134 48 146.!:_ 94 BW (1273±57g), GA (29.3±0.4 wks), or severity of RDS during the All of the infants with PFC, except one, had TxB2 levels >300pg/ first 48 h, as compared between the INO and the GLU groups.
    [Show full text]
  • Palliative Care in Critical Perinatal and Neonatal Cardiac Patients
    children Review Redefining the Relationship: Palliative Care in Critical Perinatal and Neonatal Cardiac Patients Natasha S. Afonso 1, Margaret R. Ninemire 1, Sharada H. Gowda 2, Jaime L. Jump 1,3, Regina L. Lantin-Hermoso 4, Karen E. Johnson 2, Kriti Puri 1, Kyle D. Hope 4, Erin Kritz 1, Barbara-Jo Achuff 1, Lindsey Gurganious 3 and Priya N. Bhat 1,* 1 Sections of Critical Care Medicine and Cardiology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (N.S.A.); [email protected] (M.R.N.); [email protected] (J.L.J.); [email protected] (K.P.); [email protected] (E.K.); [email protected] (B.-J.A.) 2 Section of Neonatology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (S.H.G.); [email protected] (K.E.J.) 3 Section of Palliative Care Medicine, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] 4 Section of Cardiology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (R.L.L.-H.); [email protected] (K.D.H.) * Correspondence: [email protected]; Tel.: +1-832-826-6230; Fax: +1-832-825-4252 Abstract: Patients with perinatal and neonatal congenital heart disease (CHD) represent a unique population with higher morbidity and mortality compared to other neonatal patient groups. Despite Citation: Afonso, N.S.; Ninemire, an overall improvement in long-term survival, they often require chronic care of complex medical M.R.; Gowda, S.H.; Jump, J.L.; illnesses after hospital discharge, placing a high burden of responsibility on their families.
    [Show full text]
  • Moving Neonatology Into the Modern Era of Drug Development
    Moving Neonatology into the Modern Era of Drug Development: Overview of Potential consortium projects and deliverables Mark Turner – University of Liverpool Ron Portman - Novartis Pharmaceuticals Wolfgang Göpel - The German Neonatal Network Stephen Spielberg – Consultant Moving Neonatology into the Modern Era of Drug Development: a clinical perspective Mark Turner Declarations of interest Chair, European Network for Paediatric Research at the European Medicines Agency Publically-funded European Commission FP7, NIHR, BLISS, MRC, AMR • Associate Director (International Liaison) National Institute for Health Research, Children’s Theme • Scientific Coordinator Global Research in Paediatrics (GRiP) Commercial: Pecuniary, non-personal Consultancies Product-specific / National PI: Chiesi, Shire, Non-product-specific: Janssen 3 A clinician’s view of the future Vision Differences from the present Implications for practice 4 Clinical Vision Improved outcomes due to new medicines that come to market rapidly This happens because of: Intelligent pipelines for drug development Smart trials Optimise use of existing data Minimise the impact on babies and families Feasible studies High quality data Line listings, source data verification (SDV) Networks 5 Different approach to most academic neonatal research Regulatory studies canNOT rely on Cochrane Reviews May need to recognise need for different approaches for Pragmatic trials different purposes HTA etc. Examples of differences Need for well-qualified standard of care Justifiable
    [Show full text]
  • World Neonatology, Pediatrics and Developmental Medicine Conference
    2019 Conference Announcement 2020 Journal of Emergency and Internal Medicine Vol.3 No.2 World Neonatology, Pediatrics and Developmental Medicine Conference Leonardo Milella Paediatric Hospital Giovanni XXIII, Italy, E-mail: [email protected] Neonatology deals with the study of medical care of Neonatology Meetings 2020 is being organized to Newborn Infants, especially the ill or premature broaden the scope of the research in the field of newborn. It includes medical diagnosis, treatment & neonatology, perinatology, neonatal intensive care unit prevention of diseases. (NICU), neonatal hepatitis, neonatal genetics, pediatric Conference Series LLC Ltd. is pleased to welcome you to our & neonatal nursing, neonatal CNS disorders, pediatrics World Neonatology, Pediatrics and Developmental Medicine nutrition & metabolism, neonatal & pediatric cardiology, Conference, which is to be held on September 07-08, 2020 at neonatal nutrition & maternal factors, neonatal Prague, Czech Republic. Neonatology Meeting 2020 will be an rheumatology, vaccination & immunization, neonatology inspired and strengthening worldwide gathering reflecting the research, pediatric gastroenterology, pediatric course of Pediatrics in the 21st century in a protected yet endocrinology, maternal & child care, congenital energizing state that offers an extensive variability of malformations & birth complications, and neonatal preoccupations to members of all foundations. This assembly diseases. gives a wonderful chance to talk about the most recent Target Audience: Neonatologists;
    [Show full text]
  • Neonatal ICU APPE Student Rotation
    Neonatal Intensive Care Unit APPE Student Rotation Developed by the Section of Inpatient Care Practitioners Section Advisory Group on Pharmacy Practice Experiences (PPE) Rotation Description The Neonatal Intensive Care Unit (ICU) rotation will help students become familiar with the key skills required as a clinical pharmacist in the Neonatal Intensive Care Unit (NICU). It will provide the student with the opportunity to be exposed and participate in the essential roles of the pharmacist in the NICU; including optimization of medication use through interaction with the Neonatal ICU Teams; order review; drug therapy monitoring; participation in high‐risk procedures including resuscitation and other time dependent emergencies; monitoring use of high‐risk medications; medication procurement and preparation; and provision of drug information. The goal of this rotation is to provide a clinical pharmacy practice environment for students to become familiar with the role of the pharmacist in the NICU, obtain experience in working with an interdisciplinary team and to work to optimize pharmacotherapeutic management and improve patient care and safety through helping to provide the services listed above. The student will participate in several activities to improve the student’s working knowledge and experience with NICU patients – which include a wide scope of severity from step‐down to the critically ill. Goals and Objectives The preceptor and student should agree on which goals and objectives are appropriate for the rotation based on rotation site, rotation objectives delineated by School/College of Pharmacy, rotation length, and student interests. The following are a list of potential goals and objectives: 1. Outline the workflow and pharmacy operations in the Neonatal Intensive Care Unit, as well as outline patient path from Labor and Delivery setting to hospital admission in Neonatal Intensive Care Unit.
    [Show full text]
  • NEOHEART 2020 5Th INTERNATIONAL CONFERENCE Cardiovascular Management of the Neonate OCTOBER 27-30, 2020 ADVANCE PROGRAM
    A Global Virtual Event NEOHEART 2020 5th INTERNATIONAL CONFERENCE Cardiovascular management of the neonate OCTOBER 27-30, 2020 ADVANCE PROGRAM #neoheart2020 neoheartsociety.org NEOHEART 2 0 2 0 GOES VIRTUAL We hope you and your family are safe and healthy during this difficult time. In the wake of the COVID-19 pandemic, we have paused how we traditionally host medical conferences. Our team has reimagined NeoHeart 2020 as an immersive, transformative virtual experience. The possibilities are endless. For the very first time in NeoHeart's history, we will be hosting our conference virtually. Join us as we take a step into the future. Log in and connect with a global audience. NEOHEART 2020 Cardiovascular Management of the Neonate a global virtual event October 27-30, 2020 Our promise: To deliver stimulating & insightful sessions, lively and engaging discussions, guaranteed to capture your attention. Meet hundreds of your peers from around the world. Engage with more than 100 leading experts in the field. Collaborate, Seek solutions, Share ideas, & Participate. Join the Conversation. This October. register at neoheartsociety.org NEOHEART 2020 A MESSAGE FROM THE A GLOBAL NEONATAL HEART SOCIETY VIRTUAL EVENT We hope you and your family are well. OCT.27-30, 2020 The Neonatal Heart Society in partnership with Columbia University and New York Presbyterian's Morgan Stanley Children's Hospital, is proud to host NeoHeart 2020. Our hope was to host NeoHeart in Manhattan in New York City as a live- in-person event. Due to the pandemic, the Society and its partners have re- imagined the conference as a global virtual event.
    [Show full text]
  • Beneficial Effects of Surgical Closure of Atrial Septal Defect Outweigh Potential Complications in Sick Infants
    https://www.scientificarchives.com/journal/journal-of-clinical-cardiology Journal of Clinical Cardiology Commentary Beneficial Effects of Surgical Closure of Atrial Septal Defect Outweigh Potential Complications in Sick Infants Takeshi Tsuda1,2*, Abdul M. Bhat1,2 1Nemours Cardiac Center, Alfred I. duPont Hospital for Children, Nemours Children’s Health System, 1600 Rockland Road, Wilmington, DE 19803, USA 2Department of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, 11th and Walnut, Philadelphia, PA 19107, USA *Correspondence should be addressed to Takeshi Tsuda; [email protected] Received date: February 10, 2021, Accepted date: May 18, 2021 Copyright: © 2021 Tsuda T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Infants and children with isolated atrial septal defect (ASD) usually do not develop clinical signs or symptoms. However, infants with premature birth complicated by chronic lung disease may develop certain problems including respiratory distress, dependency upon supplemental oxygen and/or mechanical ventilation, failure to thrive, and prolonged hospitalization; these are induced largely by excessive pulmonary blood flow through ASD. Although transcatheter approach is less invasive than surgery, its feasibility is often limited by anatomical conditions of ASD and the size of the patients. In these circumstances, surgical closure can be performed safely and effectively even in sick infants to improve clinical status. When transcatheter approach is not feasible, the surgical closure of ASD results in a favorable outcome by eliminating excessive pulmonary blood flow, mitigating the need of positive pressure ventilation more quickly, and promoting better physical growth.
    [Show full text]
  • Young Children with Atrial Septal Defect
    Young children with atrial septal defect Gustaf Tanghöj Department of Clinical Sciences, Paediatrics Umeå 2020 i Responsible publisher under Swedish law: The Dean of the Medical Faculty This work is protected by the Swedish Copyright Legislation (Act 1960:729) Dissertation for PhD: [email protected] ISBN: 978-91-7855-280-1 (print) ISBN: 978-91-7855-281-8 (pdf) ISSN: 0346-6612 Cover design sketched by Gustaf Tanghöj Electronic version available at: http://umu.diva-portal.org/ Printed by: Tryckservice / Print Service, Umeå University Umeå, Sweden 2020 ii “Do or do not, there is no try.” /Yoda iii iv Contents Contents v List of papers vii Abbreviations viii Definitions ix Abstract x Sammanfattning på svenska xii Introduction 1 Secundum atrial septal defect (ASD II) pathophysiology and natural history 1 ASD II indications for closure and state of the art 3 ASD II closure, risk assessment, and adverse events 4 ASD II closure in children and risk of adverse events by weight and age 5 Preterm birth and CHD 7 The preterm child’s circulation, pathophysiology and cardiac morphology 8 Preterm children with bronchopulmonary dysplasia and pulmonary hypertension 10 ASD II with bronchopulmonary dysplasia and pulmonary hypertension 11 Registries 12 Epidemiological methods 12 Key factors in introduction 15 Aim of the thesis 16 Materials and methods 17 Study design and materials, Paper I 19 Study design and materials, Papers II–III 22 Study design and materials, Paper IV 24 Ethics 25 Results 26 Paper I. Early complications after percutaneous closure of atrial septal defect in infants with procedural weight less than 15 kg 26 Paper II.
    [Show full text]